Director Shaul Yemal resigns from CNBX Pharmaceuticals board effective Dec 25, 2022

CNBX Pharmaceuticals Inc.

Shaul Yemal resigned as Director and Board Member on December 25, 2022.
Resignation was not due to any dispute with the company.
No replacement named; board vacancy remains.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Shaul Yemal

Director and Board Member

CNBX · CNBX Pharmaceuticals Inc.

Effective: 2022-12-25
Filed: December 29, 2022, 6:59 PM ET

On December 25th, 2022, Shaul Yemal resigned his position as Director and Board Member.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shaul Yemal resigned as Director and Board Member at CNBX Pharmaceuticals Inc..

Action: resigned
Role: Director and Board Member

Exact text from the filing

On December 25th, 2022, Shaul Yemal resigned his position as Director and Board Member.

View on SEC.gov

CNBX Pharmaceuticals Inc. filing history →

Source: SEC EDGAR

accession 0001683168-22-008672

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.